Core Insights - Church & Dwight Co., Inc. (CHD) has a market cap of $21.1 billion and is recognized for its strong brand portfolio, including ARM & HAMMER, Trojan, and OxiClean, emphasizing innovation and quality [1] - The company is expected to report an adjusted EPS of $0.73 for fiscal Q3 2025, reflecting a 7.6% decrease from $0.79 in the same quarter last year, although it has a history of exceeding Wall Street estimates [2] - For fiscal 2025, analysts forecast an adjusted EPS of $3.46, slightly up from $3.44 in fiscal 2024, with a projected growth of 7.5% year-over-year to $3.72 in fiscal 2026 [3] Stock Performance - Over the past 52 weeks, Church & Dwight shares have declined by 16.3%, underperforming the S&P 500 Index's gain of 16.9% and the Consumer Staples Select Sector SPDR Fund's decline of 3.2% [4] - The stock saw a marginal recovery on August 1 after reporting stronger-than-expected Q2 2025 results, with an adjusted EPS of $0.94 and revenues of $1.51 billion, driven by international sales and e-commerce, which constituted 23% of consumer sales [5] Analyst Ratings - The consensus rating for CHD stock is "Moderate Buy," with 22 analysts covering the stock: nine recommend "Strong Buy," one "Moderate Buy," eight "Hold," and four "Strong Sell." The average price target is $98.44, indicating a potential upside of 14.6% from current levels [6]

Core Insights - Church & Dwight Co., Inc. (CHD) has a market capitalization of $22.2 billion and is a leading player in the household, personal care, and specialty products sectors, known for brands like ARM & HAMMER and Trojan [1][2] - The company operates across various segments including domestic, international, and specialty products, serving consumers through retail, e-commerce, and industrial distribution channels [2] Stock Performance - CHD shares have decreased by 21.7% from their 52-week high of $116.46 and have fallen over 6% in the past three months, underperforming the Consumer Staples Select Sector SPDR Fund (XLP), which declined by 1.9% during the same period [3][4] - Year-to-date, CHD stock is down 12.9%, while XLP has returned 1%. Over the past 52 weeks, CHD shares have decreased by 12.3%, compared to XLP's 5.4% drop [4] - The stock has been trading mostly below its 50-day and 200-day moving averages since early April [4] Recent Financial Performance - On August 1, CHD reported stronger-than-expected Q2 2025 results, with adjusted EPS of $0.94 and revenues of $1.51 billion, driven by strong Consumer International sales and e-commerce, which accounted for 23% of consumer sales [5] Competitive Landscape - Rival The Clorox Company (CLX) has underperformed CHD, with CLX stock down 24.4% year-to-date and 26.1% over the past 52 weeks [6] - Despite CHD's recent underperformance, analysts maintain a moderately optimistic outlook, with a consensus rating of "Moderate Buy" and a mean price target of $101.94, representing an 11.7% premium to current levels [6]

Core Insights - Church & Dwight Co., Inc. (CHD) is enhancing its market position through a strong brand portfolio, strategic pricing, and continuous innovation, benefiting from trusted consumer brands like Arm & Hammer and OxiClean [1][10] Brand and Product Development - The Batiste brand remains a leader in dry shampoo, with the introduction of Batiste Light expanding its product line. The Hero brand is also innovating with skincare patches, contributing to CHD's growth [2] - CHD is revitalizing its gummy vitamin offerings with new formulations and flavors, including Power Plus and sugar-free options, indicating a focus on innovation and brand enhancement [3] Acquisitions and Market Expansion - The acquisition of Touchland, a leading hand sanitizer brand, strengthens CHD's position in key product categories and adds to its portfolio of power brands [4] - CHD is expanding its international presence, with organic sales in the International segment increasing by 4.8% in Q2 2025, driven by higher volumes and strong brand demand [5][10] Financial Performance and Estimates - CHD's shares have decreased by 11.8% year-to-date, compared to a 4.4% decline in the industry [8] - The company trades at a forward price-to-earnings ratio of 25.43X, higher than the industry average of 19.86X [9] - The Zacks Consensus Estimate for CHD's earnings per share (EPS) indicates a year-over-year growth of 0.9% for 2025 and 7.6% for 2026, with stable EPS estimates over the past 30 days [11]

Core Insights - The consumer-packaged goods industry features prominent players like Procter & Gamble (PG) and Church & Dwight (CHD), each with unique strategies and brand portfolios [1][2][3] Procter & Gamble (PG) - PG is a leading global company with a diverse product range, maintaining strong market share and customer loyalty despite economic challenges [4][5] - The company employs an integrated growth strategy focusing on product superiority, operational efficiency, and innovation, supported by effective digital marketing [5][7] - PG's supply chain is designed for efficiency and resilience, allowing quick responses to market demands and geopolitical disruptions [6][7] - Financially, PG shows strong free cash flow and consistent capital returns to shareholders, with projected sales growth of 2.6% and earnings growth of 3.6% in fiscal 2026 [13][23] - PG's stock trades at a forward P/E ratio of 22.85, which is lower than CHD's 26.55, indicating a more attractive valuation [18][21] Church & Dwight (CHD) - CHD has demonstrated resilience, gaining volume share in 80% of its business despite macroeconomic pressures, with nine of its 14 major brands outperforming category growth [9][10] - The company focuses on disciplined portfolio management and innovation, recently divesting non-core businesses to concentrate on growth drivers [10][12] - CHD's marketing strategy is aggressive, with a significant portion of net sales allocated to marketing, and it is enhancing its digital presence as online sales grow [11][12] - Financially, CHD's EPS is projected to grow by 1.2% in 2025, while sales are expected to decline by 0.4% [16] - CHD's stock has underperformed compared to PG, with an 8.1% decline over the past year [17][22] Comparative Analysis - PG is positioned as a stronger investment due to its scale, diversified portfolio, and operational excellence, while CHD, despite its agility and niche performance, operates on a smaller scale and faces valuation challenges [22][23]